Riva E.
130
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 4 |
| Medicina interna | 2 |
| Infección | 1 |
| Patología | 1 |
| Medicamento | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 6 |
| Farmacología y terapéutica | 2 |
| Medicina y salud | 2 |
| Problemas sociales y servicios a grupos | 1 |
| Producción | 1 |
| Edificios residenciales y afines | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| David Garrido | 5 |
| Bove V. | 3 |
| Fantl D. | 2 |
| Idrobo H. | 2 |
| Soto P. | 2 |
| Peña C. | 2 |
| Bujan W. | 1 |
| Harousseau J.L. | 1 |
| Royg M. | 1 |
| Macias J. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Herpesviral encephalitis associated with bortezomib use in a patient with multiple myeloma and associated light-chain amyloidosis
ArticleAbstract: Introduction: Bortezomib is proteasome inhibitor used in multiple myeloma treatment. The reactivatioPalabras claves:bortezomib, Case report, Encephalitis, herpesviridae, Multiple myelomaAutores:David Garrido, Riva E.Fuentes:scopusYoung age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma
ArticleAbstract: Background: Multiple myeloma is a disease of the elderly. However, 40% of patients are diagnosed befPalabras claves:Age, Multiple myeloma, Survival, TransplantationAutores:Bove V., David Garrido, Riva E.Fuentes:scopusComparative survival analysis using the International Stratification Score (ISS) in newlydiagnosed multiple myeloma in the Uruguayan population
ArticleAbstract: Background and aims. Multiple myeloma is a frequent hematologic malignancy, in which the InternationPalabras claves:Multiple myeloma, survival analysis, URUGUAYAutores:Bove V., David Garrido, Matosas V., Riva E.Fuentes:scopusSpinal cord compression due to a solitary, bulky plasmacytoma of posterior mediastinum.
ArticleAbstract: Solitary plasmacytoma is a rare clonal plasma cell tumor, representing 2-5% of plasma cell disordersPalabras claves:Extramedullary solitary plasmacytoma, Multiple myeloma, Posterior mediastinal mass, Solitary plasmacytomaAutores:Carina D.M., Cecilia G., David Garrido, Francisco G., Mariana L., Marianela P., Riva E., Victoria M.Fuentes:scopusAnalysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries
ArticleAbstract: Latin American countries represents a large fraction of patients who are treated for multiple myelomPalabras claves:ACCESS, Health care systems, Latin America Countries, Multiple myeloma, New agentsAutores:Bujan W., Conte G., Crusoe E., Durie B., Espino G., Fantl D., Garcia D.K., Harousseau J.L., Hungria V.T.d.M., Jose Willian Oliveros Alvear, Lopez Dopico J.L., Macias J., Maiolino A., Navarro Cabrera J.R., Neves L.A., Ortiz D.R., Pessoa de Magalhães Filho R.J., Riva E., Royg M., Ruiz-Arguelles G.J., Socarra Z., Vega G.Q.Fuentes:scopus